TABLE 1.

Distribution of resistance pattern among Mexican C. difficile strains.

Resistance pattern	Number of strains
	Adults		Children
	n = 63		n = 31
Antibiotic	No.	%(95CI)	No.	%(95CI)	p-value
Clindamycin (CLIN)	56	88.8 (78.4–95.4)	27	87.1 (70.1–96.4)	0.799
Levofloxacin (LEV)	60	95.2 (86.7–99.0)	24	77.4 (58.9–90.4)	0.008
Ciprofloxacin (CIPRO)	62	98.4 (91.4–99.9)	31	100 (–)	0.958
Moxifloxacin (MOX)	57	90.4 (80.4–96.4)	31	100 (–)	0.749
Rifampicin (RIF)	54	85.7 (74.6–93.2)	20	64.5 (45.3–80.7)	0.018
Linezolid (LIN)	43	68.2 (55.3–79.4)	14	45.1 (27.3–63.9)	0.031
Meropenem (MER)	42	66.6 (53.6–78.0)	23	74.1 (55.3–88.1)	0.458
Fusidic Acid (FUS)	6	9.5 (3.5–19.5)	5	16.1 (5.4–33.7)	0.349
Tetracycline (TET)	6	9.5 (3.5–19.5)	1	3.2 (0.08–16.7)	0.274
Vancomycin (VAN)		0		0
Metronidazole (MET)		0		0
Multiple resistance
CLIN, CIPRO, MERO	41	65.0 (52.0–76.6)	20	64.5 (45.3–80.7)	0.957
CLIN,LEV,CIPRO,RIF, LIN	28	44.4 (31.9–57.5)	12	38.7 (21.8–57.8)	0.597
CLIN,LEV,CIPRO,RIF, MER	38	60.3 (47.2–72.4)	14	45.1 (27.3–63.9)	0.165
CLIN,LEV,CIPRO,RIF, MER, TET	4	6.3 (1.7–15.4)		0